Peptides DB

Research-centric peptide and protocol reference hub

Follistatin-344

Research-centric overview

Share
Peptide

### Follistatin-344 Summary Follistatin-344 is a glycoprotein that plays a crucial role in the regulation of muscle growth and development by inhibiting myostatin, a negative regulator of muscle mass. Its potential therapeutic applications are being explored in various fields, including muscle wasting disorders and regenerative medicine.

Community effect ratings, structured research logs, and side-effect patterns — all fed by one anonymous form.

Effect profile (overview)

Aggregate AI baseline blended with community voting. Hover to inspect effect strengths per category.

Effect profile (AI + community): Healing & recovery 2.0/5 · Muscle & body comp 5.0/5 · Metabolic & appetite 2.0/5 · Neuro & mood 1.0/5 · Inflammation & immune 1.0/5 · Skin & aesthetics 3.0/5Healing 2.0Muscle 5.0Metabolic 2.0Neuro 1.0Sleep 0.0Inflammation 1.0Skin 3.0

Effect scores blend an AI baseline with community ratings. Open the full chart for per-category detail; rate via the Contribute button.

Research log summary heatmap

Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.

No community research logs yet. When structured logs are added, this panel will summarize typical shifts in pain, sleep, and performance.

Anonymous side-effect patterns

Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.

No anonymous side-effect reports yet. When reports are submitted, this panel will show a simple heatmap of tags like "nausea", "flushing", "improved healing", and more.

Research footprint

Last analyzed Jul 17, 2026
4
Studies indexed
1
Human
0
Animal
4
AI analyzed
Evidence mix25% human · 0% animal · 0% cellular · 0% review
Highest phase: Preclinical onlyYears covered: 2019–2021
Librarian pulse — latest actionsFull changelog ↓
  • Jul 14, 11:00 PMRe-scoredScored effects for Follistatin-344
  • Jul 7, 10:00 PMRe-scoredScored effects for Follistatin-344
  • Jun 30, 9:00 PMRe-scoredScored effects for Follistatin-344

Research & intelligence feed

Studies, clinical trials, community discussions, and news.

A Phase I, Open Label, Single Dose Study to Evaluate the Safety and Efficacy of an Injectable Follistatin Plasmid Gene Therapy in Healthy SubjectsClinical TrialClinicalTrials.govPublished Aug 18, 2022Added Apr 16, 2026

This study evaluated the safety and efficacy of an injectable follistatin plasmid gene therapy in healthy subjects. The trial was an open-label, single-dose study. Specific outcomes and numeric results were not detailed in the abstract.

Phase: PHASE1Status: COMPLETED
Semantic Scholar search for Follistatin-344StudySemanticScholarAdded Dec 12, 2025

Not reported in abstract.

Detection of black market follistatin 344.StudyPubMedPublished Jan 1, 2019Added Dec 12, 2025

Not reported in abstract.

Central serous chorioretinopathy associated with high-dose follistatin-344: a retrospective case series.StudyPubMedPublished Jan 1, 2020Added Dec 12, 2025

High-dose follistatin-344 may be associated with central serous chorioretinopathy, but the evidence is limited and based on a small case series.

Detection of black market follistatin 344.StudyPubMedPublished Jan 1, 2021Added Dec 12, 2025

Not reported in abstract.

External databases

Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.

Practical guides for Follistatin-344

How-to and safety articles applicable to every peptide in the library.

Community notes

No comments yet. Share research notes, citations, or observations below.

Comments appear immediately.

Community research logs (detail)

No community research logs yet. Use the “Contribute data” button above to share an anonymized summary of your experience.

Anonymous side-effect reporting (detail)

This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.

Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.

Librarian Changelog

Every time the Librarian touches this peptide — discovering, refreshing, scoring, or verifying — it logs the action here.

2d agoScoring70%

Scored effects for Follistatin-344

Jul 7Scoring70%

Scored effects for Follistatin-344

Jun 30Scoring70%

Scored effects for Follistatin-344

Jun 23Scoring70%

Scored effects for Follistatin-344

Jun 16Scoring70%

Scored effects for Follistatin-344

Jun 9Scoring70%

Scored effects for Follistatin-344

Jun 2Scoring70%

Scored effects for Follistatin-344

Jun 1Refreshai-researcher85%

Refreshed content for Follistatin-344

May 31Refreshai-researcher85%

Refreshed content for Follistatin-344

May 30Refreshai-researcher85%

Refreshed content for Follistatin-344

May 29Refreshai-researcher85%

Refreshed content for Follistatin-344

May 27Refreshai-researcher85%

Refreshed content for Follistatin-344

May 26Scoring70%

Scored effects for Follistatin-344

May 26Verificationai-researcher90%

Verified content for Follistatin-344: accurate

May 26task_runlibrarian-runner

Completed task: Find real articles for Follistatin-344 (thin literature)

May 26Ingestiondiscovery

Searched for real articles on Follistatin-344

Apr 20Refreshdiscovery50%

Refreshed content for Follistatin-344

Apr 20SummarySemanticScholar0%

Auto-summarized study: "Semantic Scholar search for Follistatin-344..."

Apr 17Refreshai-researcher85%

Refreshed content for Follistatin-344

Apr 16Refreshai-researcher85%

Refreshed content for Follistatin-344